HomeCompaniesMable
Mable

First personalized migraine clinic using genetics and telehealth.

Mable is a personalized migraine clinic using DNA to find and provide the right medication alongside continuous expert care Using our approach, patients have an 80% higher treatment satisfaction rate, have one extra day per week to enjoy their life and get 55% pain reduction.
Active Founders
Roman Rothaermel
Roman Rothaermel
Founder
Roman is a neuroscientist who has conducted several years of research on memory encoding in the brain, neuropharmacology and drug target characterization. During his PhD at Oxford University he uncovered a new mechanism causing brain-wide synchronization which is necessary for correct retrieval of complex memories. He also has an MSc in Neuroscience (Oxford, UK) and MSc in Biology (Tubingen, Germany).
Inna Thalmann
Inna Thalmann
Founder
Inna is Co-Founder and COO of Mable - a precision medicine company using whole genome sequencing to optimise prescribing decisions. Prior to this, Inna completed her PhD in Econometrics with a focus on Health Economics at the University of Oxford, followed by postdoctoral research focused on the development of novel phenotype algorithms to increase the cost-efficiency of clinical trials.
Mable
Founded:2019
Batch:Summer 2021
Team Size:7
Status:
Acquired
Location:London, United Kingdom